BAXTER/HYLAND GAMMIGARD S.D. AVAILABLE FOR "EMERGENCY EXEMPT USE"
Executive Summary
BAXTER/HYLAND GAMMIGARD S.D. AVAILABLE FOR "EMERGENCY EXEMPT USE" following the firm's worldwide voluntary withdrawal of Gammigard due to the product's "possible association with hepatitis C virus," Baxter told physicians in a Feb. 23 "Dear Doctor" letter. The letter instructs physicians who need to treat patients who require intravenous immunoglobulin with low IgA to "apply for emergency exempt use of Baxter's virally-inactivated investigation[al] product by contacting the company at 1- 800-423-2090."